Cart
sales@molnova.com
Bevurogant
CAS No. 1817773-66-2
Bevurogant( —— )
Catalog No. M28214 CAS No. 1817773-66-2
Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 113 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 150 | In Stock |
|
| 25MG | 306 | In Stock |
|
| 50MG | 477 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBevurogant
-
NoteResearch use only, not for human use.
-
Brief DescriptionBevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.
-
DescriptionBevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNuclear Receptor/Transcription Factor
-
TargetROR
-
Recptorp53
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1817773-66-2
-
Formula Weight532.62
-
Molecular FormulaC26H28N8O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (469.38 mM)
-
SMILES[C@@H](C)(N1C=2C(N=C(NCC3=CC=C(S(C)(=O)=O)C=N3)C1=O)=CN=C(N2)C=4C(=NC=NC4C)C5CC5)C6CC6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Messerli M, et al. Emphysema quantification and lung volumetry in chest X-ray equivalent ultralow dose CT - Intra-individual comparison with standard dose CT. Eur J Radiol. 2017 Jun;91:1-9.
molnova catalog
related products
-
RORγt Inverse agonis...
RORγt Inverse agonist 6 is an agonist of RORγt inverse. RORγt Inverse agonist 6 can be used in research on Th17-driven autoimmune diseases.
-
SR1001
SR 1001 is an inverse agonist for RORα/RORγ (Kis: 172/111 nM).
-
RORγt inverse agonis...
RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist (IC50=63.8 nM), with improved drug-like properties.
